Glucose turnover in insulinoma--a case report

Area of Science:

• Endocrinology
• Metabolic Research
• Clinical Investigation

Background:

• Investigates glucose metabolism in patients with insulinoma, a condition of chronic endogenous insulin excess.
• Utilizes [3-3H]glucose infusion to measure glucose turnover (production and disappearance) and clearance.
• Assesses hormonal levels (insulin and glucagon) and glycemia in various physiological states.

Observation:

• Before insulinoma resection, patients exhibited hypoglycemia (55 mg/dl) with elevated glucose clearance (2.8 ml/kg/min) and suppressed glucose production.
• During euglycemic glucose infusion, glucose production halted entirely despite stable insulin and glucagon levels.
• Post-resection, glycemia normalized (103 mg/dl), with slightly increased glucose production/disappearance and decreased glucose clearance.

Findings:

• Hypoglycemia in insulinoma is characterized by decreased hepatic glucose production and increased glucose clearance.
• The liver demonstrates heightened sensitivity to glycemia, suppressing glucose production at euglycemic levels.
• Hormonal regulation of hepatic glucose production in insulinoma differs from normal physiological mechanisms.

Implications:

• Understanding these altered glucose flux mechanisms is crucial for managing insulinoma.
• Highlights the liver's regulatory role in glucose homeostasis and its dysregulation in pathological insulin excess.
• Suggests potential targets for therapeutic interventions in glucose metabolism disorders.